Staff20192020202120222023
Personnel at the end of the year1741499911095
Staff turnover in EUR179,684203,664290,778233,982339,463
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)44.8547.7556.720.2963.81
Dividend per share-----
Basic earnings per share-1.82-2.738.05-9.39-0.12
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover31.330.328.825.732.2
Operating income (EBIT)-2.2-10.024.71.15.1
Earnings before taxes-4.8-12.721.01.05.1
Annual net profit/ loss-7.4-13.038.3-44.2-0.4
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets22.526.114.415.117.7
Total fixed assets37.532.262.918.313.5
Total assets60.058.377.233.431.3
Liabilities
Total short-term liabilities11.68.317.58.410.1
Total long-term liabilities38.542.61.84.61.2
Total provisions0.00.00.00.00.0
Equity capital10.07.458.020.320.0
Total liabilities60.058.377.233.431.3
Management:
María del Pilar de la Huerta Martínez
Board:
Helge Lubenow
Heikki Lanckriet
Karin Lergenmüller
Jörgen Tielmann
Karlheinz Schmelig
Shareholding in %:
Address: Hemmelrather Weg 201, 51377 Leverkusen
T: +49-214-87-63-2-0
F: +49-214-87-63-2-90
I: http://biofrontera.com
E: info@biofrontera.com